NCT06635551

Brief Summary

The aim of this study was to prospectively evaluate vascular catheter-related thrombosis and risk factors using daily bedside ultrasonography after oncologic and non-oncologic major surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 10, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

December 4, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

December 5, 2025

Status Verified

December 1, 2024

Enrollment Period

1.2 years

First QC Date

August 21, 2024

Last Update Submit

December 4, 2025

Conditions

Keywords

Central Venous CathetersVenous ThrombosisUltrasonography

Outcome Measures

Primary Outcomes (1)

  • Incidence of catheter related vascular thrombosis after surgery

    The incidence of vascular catheter-related thrombus in oncologic and non-oncologic surgery patients.

    The vascular catheter will be monitored for the duration of its stay, at least 10 days if possible.

Secondary Outcomes (5)

  • Time from vascular catheter placement to the onset of thrombus formation

    Daily assessment until vascular catheter removal, if possible for at least 10 days postoperatively

  • Relationship between demographic characteristics of patients (age, gender and additional diseases) recorded on the preoperative anesthesia assessment form and vascular catheter-related thrombosis

    From preoperative anesthesia assessment to postoperative day 10

  • Daily changes in thrombus area (cm2) from the diagnosis of vascular catheter-related thrombus to catheter removal or patient discharge

    Daily assessment until vascular catheter removal, if possible for at least 10 days postoperatively

  • The incidence of severe complications such as pulmonary embolism, cerebrovascular disease or acute coronary ischemia that may occur due to vascular catheter-related thrombosis

    Daily assessment until vascular catheter removal, if possible for at least 30 days postoperatively

  • Lenght of stay at hospital/ICU and mortality

    From date of surgery until the date of discharge of patient or date of death from any cause, whichever came first, assessed up to 10 weeks

Study Arms (2)

Catheter-related thrombosis in oncologic patients after major surgery

EXPERIMENTAL

Cancer patients who will receive central venous catheter

Diagnostic Test: Ultrasonographic evaluation of vascular catheter-related thrombosis after oncological surgery.

Catheter-related thrombosis in non-oncologic patients after major surgery

ACTIVE COMPARATOR

Patients without known cancer who will receive a central venous catheter

Diagnostic Test: Ultrasonographic evaluation of vascular catheter-related thrombosis after non-oncological surgery.

Interventions

In patients who will undergo oncological surgery and have a central venous catheter, the presence of thrombosis, its duration of occurrence and its dimensions will be evaluated by ultrasonography.

Catheter-related thrombosis in oncologic patients after major surgery

In patients who will undergo non-oncological surgery and have a central venous catheter, the presence of thrombosis, its duration of occurrence and its dimensions will be evaluated by ultrasonography.

Catheter-related thrombosis in non-oncologic patients after major surgery

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient (18-80 years old)
  • No hematological disease causing hypercoagulability
  • Not receiving anticoagulant/antifibrinolytic medications at the therapy dose
  • The vascular structure can be visualized with US
  • No thrombosis in the US control before catheter placement
  • The catheter is not inserted for renal replacement therapy

You may not qualify if:

  • Presence of renal failure
  • Pediatric patients
  • Presence of hematological malignancy
  • Inadequate US imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mersin University

Mersin, Yenişehir, 33343, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Timsit JF, Rupp M, Bouza E, Chopra V, Karpanen T, Laupland K, Lisboa T, Mermel L, Mimoz O, Parienti JJ, Poulakou G, Souweine B, Zingg W. A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill. Intensive Care Med. 2018 Jun;44(6):742-759. doi: 10.1007/s00134-018-5212-y. Epub 2018 May 12.

    PMID: 29754308BACKGROUND
  • Wu C, Zhang M, Gu W, Wang C, Zheng X, Zhang J, Zhang X, Lv S, He X, Shen X, Wei W, Wang G, Lu Y, Chen Q, Shan R, Wang L, Wu F, Shen T, Shao X, Cai J, Tao F, Cai H, Lu Q; Study Group of Central Venous Catheter-related Thrombosis. Daily point-of-care ultrasound-assessment of central venous catheter-related thrombosis in critically ill patients: a prospective multicenter study. Intensive Care Med. 2023 Apr;49(4):401-410. doi: 10.1007/s00134-023-07006-x. Epub 2023 Mar 9.

    PMID: 36892598BACKGROUND
  • Debourdeau P, Lamblin A, Debourdeau T, Marcy PY, Vazquez L. Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies. J Thromb Haemost. 2021 Nov;19(11):2659-2673. doi: 10.1111/jth.15487. Epub 2021 Aug 26.

    PMID: 34363736BACKGROUND

MeSH Terms

Conditions

Venous Thrombosis

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Levent Özdemir

    Mersin University, Faculty of Medicine, Mersin, Turkiye

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 21, 2024

First Posted

October 10, 2024

Study Start

December 4, 2024

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

December 5, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations